With a team of dedicated specialists, the New Mexico Cancer Center uses the latest technology, from blood tests and imaging ...

The announcement Sunday that former President Joe Biden was diagnosed with advanced prostate cancer has some people wondering how the disease wasn’t spotted sooner. As president, Biden had ...

Many men with aggressive prostate cancer can experience a high rate of recurrence despite treatment. A new Phase 2 clinical ...

head of the prostate cancer section at Memorial Sloan Kettering Cancer Center in New York City. “The majority of prostate cancers that are diagnosed are not the aggressive kind that we’ve been ...

Prostate cancer is the second most common ... Dr. Nitin Yerram, co-director of urologic oncology at the John Theurer Cancer Center at Hackensack University Medical Center in New Jersey, said ...

ESPN 'SportsCenter' anchor Jay Harris was joined by Michael Strahan on 'Good Morning America' as he bravely announced that he ...

M.D., a medical oncologist and prostate cancer researcher at The University of Texas MD Anderson Cancer Center. "The overwhelming majority of prostate cancers — 99% plus — are hormone ...

Darolutamide (Nubeqa) is granted FDA approval for metastatic castration-sensitive prostate cancer, enhancing survival and ...

vice president of precision oncology at the Fred Hutchinson Cancer Center in Seattle and head of the prostate cancer research program at the Fred Hutch/University of Washington/Seattle Children’ ...

Researchers at the University of Michigan Rogel Cancer Center identified a gene that plays a key role in prostate cancer ...

said Dr. Matthew Smith of Massachusetts General Brigham Cancer Center.“It’s very treatable, but not curable,” Smith said.What are the treatment options?Prostate cancer can be treated with ...